Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy
Authors:
- Li-Chia HuangLHLi-Chia Huang
- Wen-Chien TingWTWen-Chien Ting
- Lu-Min ChenLCLu-Min Chen
- Ta-Yuan ChangTCTa-Yuan Chang
- Te-Ling LuTLTe-Ling Lu
- Yu-Hsuan LanYLYu-Hsuan Lan
- Chia-Chu LiuCLChia-Chu Liu
- Wen-Hui YangWYWen-Hui Yang
- Hong-Zin LeeHLHong-Zin Lee
- Chi-Jeng HsiehCHChi-Jeng Hsieh
- Bo-Ying BaoBBBo-Ying Bao
Open Access
- 1 November 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (11) , 3068-3074
Abstract
Recent genomewide association studies have identified several prostate cancer susceptibility variants. However, the association between these variants and biochemical failure in prostate cancer patients receiving radical prostatectomy has not been determined. We systematically evaluated 20 prostate cancer–associated single-nucleotide polymorphisms in a cohort of 320 localized prostate cancer patients receiving radical prostatectomy. Each single-nucleotide polymorphism found to be associated with the recurrence of prostate-specific antigen was further analyzed by Kaplan-Meier analysis and Cox regression model. Three prostate cancer susceptibility single-nucleotide polymorphisms (rs1447295 at 8q24, rs7920517 and rs10993994 at 10q11) were associated with prostate-specific antigen recurrence (P < 0.02). Of these, rs7920517 and rs10993994, which were in strong linkage disequilibrium (r2 = 0.91), also showed significant associations with poor prostate-specific antigen–free survival following radical prostatectomy (log-rank test; P < 0.01). The associations remained significant in our multivariate Cox proportional hazards analysis after adjusting for other clinicopathologic risk covariates (P < 0.01). In conclusion, loci associated with risk for prostate cancer, such as rs7920517 and rs10993994, might also be used to predict the recurrence of prostate-specific antigen in prostate cancer patients receiving radical prostatectomy. (Cancer Epidemiol Biomarkers Prev 2009;18(11):3068–74)Keywords
This publication has 41 references indexed in Scilit:
- Individual and cumulative effect of prostate cancer risk‐associated variants on clinicopathologic variables in 5,895 prostate cancer patientsThe Prostate, 2009
- Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibilityProceedings of the National Academy of Sciences, 2009
- Generalizability of Associations from Prostate Cancer Genome-Wide Association Studies in Multiple PopulationsCancer Epidemiology, Biomarkers & Prevention, 2009
- Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskHuman Molecular Genetics, 2009
- Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2008
- Multiple Loci With Different Cancer Specificities Within the 8q24 Gene DesertJNCI: Journal of the National Cancer Institute, 2008
- Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerNature Genetics, 2008
- A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21Nature Genetics, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003